Anaptysbio (ANAB) FCF Margin (2016 - 2026)
Anaptysbio (ANAB) posted FCF Margin of 101.49% for Q1 2026, down 177.74% on a QoQ basis from 130.55% in Q4 2025, and down 6292.0% year-over-year from 1.64% in Q1 2025.
Anaptysbio (ANAB) FCF Margin (2016 - 2026) Analysis & Trends
Anaptysbio's FCF Margin history runs 11 years deep, the most recent figure standing at 101.49% for Q1 2026.
- Quarterly FCF Margin fell 6292.0% year-over-year to 101.49% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.54% (up 14068.0% YoY) and the FY2025 annual result came in at 8.36%, up 15663.0% from the prior year.
- FCF Margin was 101.49% for Q1 2026 at Anaptysbio, down from 130.55% in the prior quarter.
- Across five years, FCF Margin topped out at 130.55% in Q4 2025 and bottomed at 2172.06% in Q1 2022.
- A 5-year average of 650.96% and a median of 266.7% in 2024 frame the typical range for FCF Margin.
- Peak annual rise in FCF Margin reached 228833 bps in 2022, while the deepest fall reached 202489 bps in 2022.
- Anaptysbio's FCF Margin stood at 216.22% in 2022, then tumbled by 78 bps to 384.55% in 2023, then jumped by 31 bps to 266.7% in 2024, then soared by 149 bps to 130.55% in 2025, then sank by 178 bps to 101.49% in 2026.
- Business Quant data shows ANAB's FCF Margin at 101.49% in Q1 2026, 130.55% in Q4 2025, and 54.56% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.45% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Anaptysbio | 1.55 Bn | 1.27 Bn | - | -101.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -101.49% |
| Dec 31, 2025 | 130.55% |
| Sep 30, 2025 | -54.56% |
| Jun 30, 2025 | -181.05% |
| Mar 31, 2025 | -38.57% |
| Dec 31, 2024 | -266.70% |
| Sep 30, 2024 | -66.89% |
| Jun 30, 2024 | -194.65% |
| Mar 31, 2024 | -519.29% |
| Dec 31, 2023 | -384.55% |
| Sep 30, 2023 | -1,104.16% |
| Jun 30, 2023 | -739.86% |
| Mar 31, 2023 | -1,800.80% |
| Dec 31, 2022 | -216.22% |
| Sep 30, 2022 | -1,374.71% |
| Jun 30, 2022 | -1,981.25% |
| Mar 31, 2022 | -2,172.06% |
| Dec 31, 2021 | -2,504.55% |
| Sep 30, 2021 | -29.19% |
| Jun 30, 2021 | 43.64% |